Imanix
Imanix is Imatinib, a BCR-ABL tyrosine kinase inhibitor. It is indicated for chronic myeloid leukemia, gastrointestinal stromal tumor, and other kinase-driven diseases and works by targeting abnormal tyrosine kinases such as BCR-ABL, KIT, and PDGFR.
Features
| Product Name | Imanix |
| Generic Name | Imatinib |
| Formulation | Tablet |
| Available Pack Size | 400mg- 5x6’s, 100mg- 3x10’s |
| Available Strength | 100MG , 400MG |